4-Methyl-α-ethylaminopentiophenone
Chemical compound
From Wikipedia, the free encyclopedia
4-Methyl-α-ethylaminopentiophenone (4-MEAP) is a designer drug of the cathinone class.[2][3] It is a higher homolog of 4-methylpentedrone (4-MPD) with an ethyl group in place of the methyl group. 4-MEAP has been found in samples of drugs sold as 4-MPD.[4]
Other names4‑MEAP;
4‑MEAPP; N-Ethyl-4'-methylnorpentedrone; 2-(Ethylamino)-1-(4-methylphenyl)-1-pentanone; 4-Methyl-alpha-ethylaminopentiophenone;
4‑methyl‑NEPLegal status
- BR: Class F2 (Prohibited psychotropics)[1]
- CA: Schedule I
- DE: NpSG (Industrial and scientific use only)
- UK: Class B
- US: Schedule I
CAS Number
- 746540-82-9
18297-05-7 (HCl)
| Clinical data | |
|---|---|
| Other names | 4‑MEAP;
4‑MEAPP; N-Ethyl-4'-methylnorpentedrone; 2-(Ethylamino)-1-(4-methylphenyl)-1-pentanone; 4-Methyl-alpha-ethylaminopentiophenone; 4‑methyl‑NEP |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO |
| Molar mass | 219.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
In the United States, 4-MEAP is a Schedule I Controlled Substance.[5][6]